{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:24:37Z","timestamp":1787570677064,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:p>Amniotic fluid embolism (AFE) is a rare, life-threatening obstetric event associated with extremely high maternal and perinatal morbidity and mortality with no known definitive pathophysiologic pathway. Current recommended management strategies are mainly supportive and include high-quality cardiopulmonary resuscitation and prompt delivery of the potentially viable fetus to improve neonatal survival and maternal resuscitation. More recently, case reports have described success in the resuscitation of patients with presumed AFE with a protocol that includes intravenous administration of atropine (1 mg), ondansetron (8 mg), and ketorolac (30 mg). The currently available evidence for the use of atropine, ondansetron, and ketorolac to treat AFE is limited, consisting of only case reports. As a result, the potential harms, including worsening of bleeding or coagulopathy, worsening kidney function, maternal tachycardia, cardiac arrhythmias, and myocardial injury, with the use of atropine, ondansetron, and ketorolac in cases of suspected AFE must be considered. We caution against the widespread use of this protocol for suspected cases of AFE and remind clinicians of the many disappointing histories of medical interventions later discredited. We recommend that adequately oxygenating, supporting blood pressure, treating heart failure, and aggressively managing coagulopathy remain the mainstays of therapy and should be recognized as the standard of care.<\/jats:p>","DOI":"10.1097\/aog.0000000000006095","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T21:00:16Z","timestamp":1761253216000},"page":"780-784","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Use of Atropine, Ondansetron, and Ketorolac in Suspected Amniotic Fluid Embolism"],"prefix":"10.1097","volume":"147","author":[{"given":"Luis D.","family":"Pacheco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon M.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"R1-20260824","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ajog.2019.07.036","article-title":"Amniotic fluid embolism: principles of early clinical management","volume":"222","author":"Pacheco","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20260824","doi-asserted-by":"crossref","first-page":"B16","DOI":"10.1016\/j.ajog.2016.03.012","article-title":"Amniotic fluid embolism: diagnosis and management","volume":"215","author":"Pacheco","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20260824","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajog.2016.06.037","article-title":"Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies","volume":"215","author":"Clark","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R4-20260824","first-page":"9658708","article-title":"Rotational thromboelastometry-guided venoarterial extracorporeal membrane oxygenation in the treatment of amniotic fluid embolism","volume":"2022","author":"Wothe","year":"2022","journal-title":"Case Rep Obstet Gynecol"},{"key":"R5-20260824","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/NMC.0000000000000970","article-title":"Extracorporeal cardiopulmonary resuscitation for amniotic fluid embolism: review and case report","volume":"49","author":"Sundin","year":"2024","journal-title":"MCN Am J Matern Child Nurs"},{"key":"R6-20260824","doi-asserted-by":"crossref","first-page":"8458375","DOI":"10.1155\/2017\/8458375","article-title":"Atypical amniotic fluid embolism managed with a novel therapeutic regimen","volume":"2017","author":"Rezai","year":"2017","journal-title":"Case Rep Obstet Gynecol"},{"key":"R7-20260824","first-page":"e75212","article-title":"Amniotic fluid embolism after cervical ripening","volume":"16","author":"French","year":"2024","journal-title":"Cureus"},{"key":"R8-20260824","doi-asserted-by":"crossref","first-page":"253","DOI":"10.31486\/toj.21.0107","article-title":"Atropine, ondansetron, and ketorolac: supplemental management of amniotic fluid embolism","volume":"22","author":"Long","year":"2022","journal-title":"Ochsner J"},{"key":"R9-20260824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5348\/100109Z08AB2022CR","article-title":"Atypical amniotic fluid embolism successfully treated with a novel protocol: a case report","volume":"8","author":"Berry","year":"2022","journal-title":"J Case Rep Images Obstet Gynecol"},{"key":"R10-20260824","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1159\/000438536","article-title":"Effect of simvastatin on 5-HT and 5-HTT in a rat model of pulmonary artery hypertension","volume":"37","author":"Jiang","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"R11-20260824","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1113\/expphysiol.1990.sp003461","article-title":"The role of platelets in the reflex tachypnoeic response to miliary pulmonary embolism in anaesthetized rabbits","volume":"75","author":"Armstrong","year":"1990","journal-title":"Exp Physiol"},{"key":"R12-20260824","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1111\/j.1476-5381.1995.tb16410.x","article-title":"Reflex circulatory collapse following intrapulmonary entrapment of activated platelets: mediation via 5-HT3 receptor stimulation","volume":"116","author":"Lea\u00f1os","year":"1995","journal-title":"Br J Pharmacol"},{"key":"R13-20260824","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.autneu.2004.12.001","article-title":"Low-dose atropine amplifies cardiac vagal modulation and increases dynamic baroreflex function in humans","volume":"118","author":"Cho","year":"2005","journal-title":"Auton Neurosci"},{"key":"R14-20260824","first-page":"4589636","article-title":"Amniotic fluid embolism treated with veno-arterial extracorporeal membrane oxygenation","volume":"2019","author":"Gitman","year":"2019","journal-title":"Case Rep Crit Care"},{"key":"R15-20260824","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1034\/j.1399-6576.2000.440113.x","article-title":"Platelet dysfunction after intravenous ketorolac or propacetamol","volume":"44","author":"Niemi","year":"2000","journal-title":"Acta Anaesthesiol Scand"},{"key":"R16-20260824","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2022.05.003","article-title":"Acute kidney injury associated with non-steroidal anti-inflammatory drugs","volume":"101","author":"Klomjit","year":"2022","journal-title":"Eur J Intern Med"},{"key":"R17-20260824","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1161\/CIR.0000000000001309","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines [published erratum appears in Circulation 2025;151:e865]","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"R18-20260824","first-page":"279","article-title":"The pharmacologic management of cardiac arrest","volume":"42","author":"Singh","year":"2024","journal-title":"Cardiol Clin"},{"key":"R19-20260824","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1161\/CIR.0000000000000905","article-title":"Drug-induced arrhythmias: a scientific statement from the American Heart Association","volume":"142","author":"Tisdale","year":"2020","journal-title":"Circulation"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:00:13Z","timestamp":1787569213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006095","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"2025-05-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}